Arantza Muriana

/Tag:Arantza Muriana

Bionaturis Group takes part in two events in USA in June

Bionaturis Group representatives will showcase the biotechnological group offer in two relevant events in USA in June: the World Preclinical Congress (Boston) and the Bio International Convention (San Diego).

Biobide’s Management Director, Arantza Muriana, will take part in the first one, attending the programme Predicting Drug Toxicity and she will present the scientific poster titled “Toxicity Profiling Using a Battery of Assays in Zebrafish Embryos Including Teratogenicity, Behavior, Cardiotoxicity, Ototoxicity and Hepatotoxicity“ on 13 and 14th, June. “Our experience and broad offer of assays with zebrafish as animal model as well as the importance that USA has for Biobide –our subsidiary is located in Maryland and we are included in the exclusive group of Spanish companies that work with the NIEHS- turn the World Preclinical Congress into an essential event to consolidate the relationships with our current customers and stablish new ones”, Arantza Muriana has stated.

The World Preclinical Congress will tackle the latest trends and technologies related to the drug discovery. It is a multidisciplinary event attended by experts from different sectors such as chemical, biological and pharmaceutical ones, among others.

To arrange a meeting with Biobide in Boston, please, write to

For further information about the World Preclinical Congress, visit its official website.

Attending the Bio International Convention once again

Bionaturis Group will not miss its annual appointment with the global biotechnology taking part in the Bio International Convention, considered the most relevant event in the biotechnological sector worldwide. From 19 to 22th, June, Biobide’s General Manager, Andoni Cruz, and Bionaturis CSO, Juan Jose Infante, will showcase the broad offer of premium products and services for Human and Animal Health in this relevant forum in Bionaturis Group schedule.

Bionaturis Group arrives to this international forum after signing relevant license […]

June 8th, 2017|Blog english, congress|Comments Off on Bionaturis Group takes part in two events in USA in June

Bionaturis Group strengthens its presence in BioSpain 2016

The acquisition of ZIP Solutions strengthens the presence of Bionaturis Group in BIOSPAIN 2016, the biggest country-based event in Europe. The main goal of the biotechnological group in this international forum is increasing the number of national and international customers. In order to achieve this goal, Bionaturis Group will showcase the competitive advantages of our premium services of development of biotechnological active principles for human and animal health and preclinical research by using Zebrafish as animal model.

The capacity of Bionaturis Group has grown up recently after acquisition ZIP, including its two proprietary technologies – Zera® and Splittera. Both technologies are key for improving the design of biological active principles. Zera® leads to increasing production yields in any type of biofactory.  Additionally, it improves the antigenic properties of vaccines. Splittera -worldwide out-licensed to a leading multination company- is a revolutionary technology making protein purification by affinity more simple and universal. It also provides new methods for making antibody-drug conjugates and improvement reagents in diagnostics. After joining ZIP’s assets to those of Bionaturis and Biobide –a company specialized in development of toxicity and efficacy preclinical assays in Zebrafish -, “our total offer brings together into the same biotechnological group innovative and highly specialized solutions that have already built loyalty among customers from different sectors: companies making active principles for agriculture, livestock, petrochemical, cosmetics; pharmaceutical companies developing new candidates for cancer and minority diseases; or industrial groups leaders in offering technologies for production in biotechnology. In BIOSPAIN we are going to show why our services have given competitive advantages to these companies”, the Chief Scientific Officer, Juan Jose Infante, has stated.

The event, organized by the Spanish Association for Biotech Companies (ASEBIO, in Spanish), and SPRI (the Basque Agency for […]

September 13th, 2016|Blog english, congress|Comments Off on Bionaturis Group strengthens its presence in BioSpain 2016

Biobide hits September with three international events

Eurotox 2016, the European Teratology Society (ETS) Meeting and the IV International Congress of Research and Innovation of Neurodegenerative Diseases are the three international events for Biobide -Bionaturis Group- to hit September. The first one, organized by the European Societies of Toxicology, will be held in Seville on 4-7th, September, with the theme “Protecting Public and Environmental Health by Understanding and Communicating Toxicology”.

The organization of this international event, which has received more than 900 abstracts to be presented as posters, has planned six Continuing Education Courses, 16 Symposia, 10 Workshops as well as Keynote Lectures from key scientists. More than 50 companies have provided their supports as exhibitors. Biobide will be one of them with the booth number 18, assisted by Arantza Muriana, the R&D Management Director of Biobide.

“The presence of Biobide in international forums is essential to be informed and updated about the news and needs of our sector as well as in the business field strictly. On the other hand, these events confirm us the increasing interest of companies and institutions in the use of zebrafish as an alternative animal model, which makes us improve our services constantly and, then, our competitiveness”, Arantza Muriana has stated.

ETS Meeting, in Dublin

The second meeting in Biobide’s schedule in September will be in Dublin (Ireland) for the 44 edition of the European Teratology Society (ETS) Meeting, held on 11-14th. This event will celebrate lectures and forums about relevant topics such as maternal health in pregnancy or the regulatory updates about developmental and reproductive toxicology.

During this high-level event, Biobide will present three scientific posters titled “An inter-laboratory validation of the zebrafish embryo assay for the detection of developmental toxicity”, “Standarized Light/Dark preference test for anxiety and stress research using […]

August 30th, 2016|Blog english, congress|Comments Off on Biobide hits September with three international events

Biobide takes part in a research about Malaria funded by Melinda and Bill Gates

Biobide (Bionaturis Group) has recently participated in a drug discovery research against malaria, a disease that causes about 440,000 deaths each year worldwide. The collaborative international project supported by Melinda and Bill Gates has the main goal of going from Hits to Leads among a selection of 400 compounds –included in the Malaria Box- to which researchers from 30 different countries have had access in the lastest two years. The final end is public institutions and the industry sharing more open knowledge in order to progress in new joint developments.

The promising results have just been published in a scientific paper and include the toxicity assays in zebrafish performed by Biobide to test the potential toxicity of the candidates to fight malaria. “Our presence in this study shows the versatility and usefulness of the zebrafish as animal model for drug discovery, as well as our expertise in this field. In addition to the obvious scientific value, this collaborative project has also a very relevant social value for Biobide, that is contributing in this way to find solutions for a disease that affected 95 countries worldwide in 2015”, the R&D Management Director at Biobide, Arantza Muriana, has stated.

In the 290 assays made by the different researchers for this study, 130 compounds have shown potential action against malaria which paves the way for a future election of the most suitable ones to develop new drugs. Additionally, some of these compounds have also shown outstanding activity against other disease agents, including bacteria, fungi, other parasites and even human cancer cells. In fact, these positive results have ignited over 30 drug development program devoted to fight different diseases. This initiative has been so satisfying that promoters are already repeating the […]

August 2nd, 2016|Blog english|Comments Off on Biobide takes part in a research about Malaria funded by Melinda and Bill Gates

Biobide strengthens its participation in international events

The schedule of Biobide scientists this spring is taken by very relevant international events in the sector. This week, the company acquired by Bionaturis Group and specialized in the use of zebrafish as animal model, presents two scientific posters in the Society of Environmental Toxicology and Chemistry (SETAC) Europe 26th Annual Meeting, 22-26 May 2016, at La Cite in Nantes, France.  Biobide also participates in the conference Measuring Behaviour 2016, hold in Dublin, with the research about the relationship between stress and exposure to light in this animal model.

R&D Management Director at Biobide, Arantza Muriana, will lead the presentation in SETAC 2016 of the posters titled ‘Testing toxicity of graphene oxide in zebrafish embryos’ and ‘Toxicity Profiling of Flame Retardants in Zebrafish’, both using zebrafish as animal model for varied toxicity and efficacy assays. The first one addresses the study of toxicity of graphene oxide, a very common material to produce goods used in our daily life, while the second one tackles the study of teratogenicity (possibilities of malformation in the development of the fetus in pregnant women), cardiotoxicity, hepatotoxicity and behavioral alterations in some flame retardants compounds found in everyday household products, to which people are regularly exposed. 

In addition to the presentation of these posters, Arantza Muriana and the Study Director, Virginia Caballero, will respond the large number of applications for one-to-one meetings in this event, considered the most important one in this specialized area in Europe. More than 2,000 scientists from 60 different countries will attend this event addressing relevant topics such as the climate change and contaminants or the production of cosmetics, among others.

Behaviour analysis

At the same time, Biobide takes part this week in the conference Measuring Behaviour 2016, considered the main interdisciplinary […]

May 25th, 2016|Blog english, congress|Comments Off on Biobide strengthens its participation in international events

Biobide coordinates a course on zebrafish in the international annual conference of the Society of Toxicology (SOT) in New Orleans

Biobide (part of Bionaturis Group) participates in the most relevant scientific event devoted to toxicology and toxicity in the world, SOT and TOX Expo, held from 13rd March in New Orleans (USA). The participation of the company, which has grown in the latest meetings, includes the coordination of a course on zebrafish, the display of two scientific posters and the presence in the exhibition area with their own booth (number #1128).

The R&D Management Director at Biobide, Arantza Muriana, along with Mamta Behl from the NIH-NIEHS, is in charge of coordinating the course titled ‘Zebrafish As a Tool in Toxicology and Drug Discovery Screening’, held on March 13rd. The academic program, in which six experts will take part, aims to provide insight on the current developments in the use of zebrafish in the field of toxicology and drug safety and efficacy assessment, highlighting some ongoing challenges in the field. Specifically, Arantza Muriana will teach the chapter devoted to ‘Innovative Zebrafish Hepatotoxicity, Cardiotoxicity, and Neurobehavioral Toxicity Assays for Drug Selection”.

In addition to this course, Celia Quevedo, Study Director of Biobide will present on the 16th of March two scientific posters -number #1927 and #3299- with the collaboration of the company Stemina and the NIH-NIEHS, respectively. Both posters, which are included in the section titled Developmental Toxicology (Non Rodent)’, address the versatility of zebrafish to analyze toxicity, safety and efficacy of compounds.

“Our outstanding participation in such a relevant international congress as the SOT shows our expertise and confirms our position as partners of choice in the zebrafish sector worldwide”, Arantza Muriana has stated. Some months ago, Biobide set up a subsidiary in the USA, in the State of Maryland, and, recently they have signed a contract with the […]

March 10th, 2016|Blog english, congress|Comments Off on Biobide coordinates a course on zebrafish in the international annual conference of the Society of Toxicology (SOT) in New Orleans

Arantza Muriana, honored with the prize Business Manager of the Year in Guipuzcoa by Aspegi Asociation

R&D Management Director and co-founder of BBD BioPhenix-Biobide (part of Bionaturis Group), Arantza Muriana, has been honoured with the prize Business Manager of the Year in Guipuzcoa by the Professional and Business Women Association from Guipuzcoa, Aspegi (in Spanish).  

The ceremony to collect the awards, whose winners have just been published, will be hold on the 10th of March at the Aquarium of San Sebastian. Among the winners in this first edition, Ana Belén Juaristi, General Manager of Engranajes Juaristi, who has been honored within the category Business Woman of the Year as well. With these awards, Aspegi aims to recognize the role of women in business, making more visible their significant contribution to the economic development in the area.

Bachelor of Pharmacy, Master degree in R+D+i of New Drugs and MBA, Arantza Muriana started working one decade ago in the field of Clinical Trials and, after a stay in the Salk Institute in California studying the zebrafish in the Preclinical Area, she came back to the Basque Country to join Biobide in its first stage. Nowadays, she is one of the co-founders of the company and the R&D Management Director, a relevant position that includes, among others tasks, management of the company’s R&D, the intermediation with pharmaceutical, biotechnology and chemical companies, or attendance at international events in the sector to present their innovations.

Biobide, an international reference company using zebrafish as animal model, offers tailor made solutions to customers all over the world to maximize R+D productivity and minimize risks in the Drug Discovery process, helping on the selection of more successful drug candidates (safer and more efficient). The latest milestones achieved by Biobide have been the foundation of a subsidiary in USA and the sign […]

March 7th, 2016|Blog english|Comments Off on Arantza Muriana, honored with the prize Business Manager of the Year in Guipuzcoa by Aspegi Asociation

Bionaturis Group takes part in the North America SETAC Meeting, in Utah

Delegates of Bionaturis Group are attending this week the North American Meeting of the Environmental Toxicology Society (SETAC), held in Salt Lake City (Utah). This international event gathers more than 1,900 scientists, assessors, regulators and managers from 40 different countries to analyze the new issues in the sector through more than 1,600 presentations in only a week.


November 5th, 2015|Blog english, congress|Comments Off on Bionaturis Group takes part in the North America SETAC Meeting, in Utah

BBD BioPhenix shows the advantages of zebrafish in the SOT 2015 Annual Meeting and TOX Expo

Arantza Muriana, R&D Management Director at BBD BioPhenix (Bionaturis Group), is the delegate in the SOT 2015 Annual Meeting and TOX Expo hold from 22nd March in San Diego (USA). BBD BioPhenix –an international reference company in drug screening and the use of zebrafish as animal model in efficacy and toxicity assays for pharmaceutical, biotechnological, chemical and cosmetic sectors, among others- is one of the 350 companies in the world attending this international event that every year receives more than 6.500 attendees.

Besides its presence in exhibition and partnering zones, BBD BioPhenix will present a scientific poster titled ‘Screening of New Compounds That Alter Sleep-Wake State Alteration in Zebrafish’, which describes trials done with some anxiolytic drugs to analize how they can alter Sleep-Wake States in humans, through the Behavior alterations´ assay in zebrafish.

“Attending to this event is very relevant to consolidate our international customers and establish new high-level contacts that let us growing more and more”, Arantza Muriana has stated. The versatility of zebrafish and the drug screening automated processes in BBD BioPhenix provide a better selection of candidates, decreasing time and cost in the new active compounds discovery.

For further information about the SOT 2015 Annual Meeting, organized by the Society of Toxicology, please click here

March 16th, 2015|Blog english, congress|Comments Off on BBD BioPhenix shows the advantages of zebrafish in the SOT 2015 Annual Meeting and TOX Expo

“BioSpain 2014 has confirmed our position in the sector”

The delegates of Bionaturis Group at BioSpain 2014 has confirmed its positioning in the sector. In just three days they hold 40 one-to-one meetings to bolster existing business relationships and starting new collaborations for the next future.

“The quality and fruitfully meetings hold there demonstrate that we are in the right path. There are more and more multinational companies and institutions that are interested in working with us to move forward innovative solutions to the market. The unique features of the FLYLIFE platform to develop biological drugs and the versatility of the zebrafish animal model to optimize the drug discovery process were the hot topics during the meetings. A perfect blend between innovation and international expansion with a newborn effective presence in China makes us a perfect partner of choice”, the delegates have stated.

BBD BioPhenix presentation

Besides taking part as expositor within the Bionaturis Group stand (booth B9), BBD BioPhenix  gave a speech as part of the workshop titled “Key Enabling Technologies Applied to BIO”. In particular, R&D Manager, Arantza Muriana, delivered the conference “Key Enabling Technologies, fundamental part of zebrafish based screenings”.

In total, more than 3,000 partnering meetings has been hold in this forum and the presence of national and international investors has gained special relevance this edition. Check the highlights at #BioSpain2014.



September 30th, 2014|Blog english, Press english|Comments Off on “BioSpain 2014 has confirmed our position in the sector”

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.